Apixaban and VKAs have similar risks
Sikorska M, Chmiel J, Papuga-Szela E, Broniatowska E, Undas A. Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study. J Cardiovasc Pharmacol. 2024;84:36. doi:10.1097/FJC.0000000000001578